US STOCK

TEVA Stock Analysis

US stocks · market data · technical indicators

Teva Pharmaceutical Industries Limited American Depositary Shares

TEVAUS stocks

Quote delayed 15 min

9/11 上午11:43 updated

$36.35

-0.50-1.36%

Open

$36.37

High

$36.75

Low

$36.04

Volume

400.71萬

TEVA price history

-1.06%

Open

36.74

Latest

36.35

High

38.10

Low

36.05

Average

36.87

AI Composite Technical Analysis

Beta

Hold

Formula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)

AI Score45

Score range 0–100; a higher score indicates a stronger buy signal

Market Status

Hold

Current Price$36.35

Target Price$34.533

Change %-1.36%

Institutional

Net Selling

Foreign Ownership

Reducing

Market Heat

Cautious

Fundamentals (US)

P/E Ratio

61.61x

ROE

9.69%

P/B Ratio

5.46x

Dividend Yield

Market Insight

The score sits in neutral territory (45/100). Waiting for a clearer signal may be warranted.

This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.

Financial snapshot

Yahoo Finance

TEVA - Teva Pharmaceutical Industries Limited

EPS

0.59USD

Forward EPS

3.07USD

P/E

61.61x

Forward P/E

11.84x

P/B

5.46x

ROE

9.69%

ROA

5.13%

Operating margin

4.03%

Profit margin

4.08%

Revenue growth

-0.80%

Earnings growth

Dividend yield

Financial statements

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$4.14B	$3.98B	$4.71B	$4.48B	$4.18B
Gross profit	$2.15B	$1.97B	$2.66B	$2.30B	$2.10B
Operating income	$149.00M	$759.00M	$1.27B	$1.07B	$899.00M
Net income	-$576.00M	$369.00M	$480.00M	$433.00M	$282.00M
Basic EPS	-0.49	0.32	0.42	0.38	0.25
Diluted EPS	-0.49	0.31	0.41	0.37	0.24

Estimates vs actuals

Next earnings

2026-11-04

EPS estimate

0.70

Revenue estimate

$4.23B

Last surprise

-81.46%

Date	Estimate	Actual	Surprise
2026-11-04	0.71	Not reported	—
2026-07-29	0.11	0.02	-81.46%
2026-04-29	0.46	0.53	+16.23%
2026-01-28	0.64	0.96	+50.17%
2025-11-05	0.67	0.78	+15.74%
2025-07-30	0.62	0.66	+7.31%
2025-05-07	0.46	0.52	+12.20%
2025-01-29	0.70	0.71	+1.09%
2024-11-06	0.66	0.69	+4.38%
2024-07-31	0.55	0.61	+10.74%
2024-05-08	0.51	0.48	-6.69%
2024-01-31	0.76	1.00	+31.74%

Institutional holders

Institution	Quarter	Value held	Portfolio weight
BlackRock Inc.	2024-06-30	$698.6M	0.02%
STATE STREET CORP	2026-06-30	$641.6M	0.02%
Bridgewater Associates, LP	2026-06-30	$44.9M	0.18%
VANGUARD GROUP INC	2025-12-31	$28.5M	0.00%
TWO SIGMA INVESTMENTS, LP	2026-06-30	$7.8M	0.01%
CITADEL ADVISORS LLC	2026-06-30	$2.5M	0.00%

13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.

Analyst ratings

12 analysts

Mean target

$41.60

Target range

$33.00 – $50.00

Implied upside

14.44%

Strong buy

Buy

Hold

Sell

Strong sell